We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Teva, Glaxo Settle Suit Over Generic Lamictal

Law360 (February 17, 2005, 12:00 AM EST) -- Teva Pharmaceutical and GlaxoSmithKline have settled their patent litigation over Glaxo’s Lamictal with a deal under which Teva will be allowed to launch an exclusive generic version later this year....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.